Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in Acute-on-Chronic Liver Failure
NCT01937130Phase 2Terminated
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Sep 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of emricasan in acute-on-chronic liver failure (ACLF), sponsored by Conatus Pharmaceuticals Inc.. Started Sep 2013; status: terminated.
02
Drugs
emricasan
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT01937130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937130.